Optimizing treatment to control LDL cholesterol using machine learning
Deiby Boneu Yepez1, David Sierra Porta2, Liz Morales Aguas3
1Ciencias básicas, programa de medicina, Corporación Universitaria Rafael Núñez, Cartagena, Bolívar, Colombia; Ciencias básicas, Maestría en estadística aplicada y ciencia de datos, Universidad Tecnológica de Bolívar, Cartagena, Bolívar, Colombia; Centro de Diagnostico Cardiológico SAS Cartagena, Bolívar, Colombia; TimeMed-IA Cartagena, Bolívar, Colombia.
Artificial intelligence models, specifically Random Forest Classifier, can optimize LDL cholesterol control in high-risk cardiovascular patients. These AI tools aid clinicians in selecting personalized therapies to effectively manage cardiovascular disease risk factors.
Area of Science:
- Cardiology
- Medical Informatics
- Artificial Intelligence
Background:
- Elevated LDL cholesterol is a primary risk factor for cardiovascular diseases.
- Effective therapy is crucial for reducing cardiovascular disease incidence.
- Artificial intelligence (AI) offers potential for personalized patient treatment selection.
Purpose of the Study:
- To identify the optimal artificial intelligence model for recommending individualized LDL-lowering therapy.
- To assess AI model performance in tailoring treatment based on patient cardiovascular risk factors.
Main Methods:
- Compared machine learning models including RandomForestClassifier, GradientBoostClassifier, and others.
- Evaluated model ability to predict optimal individualized therapy for cardiovascular patients.
- Utilized a dataset of 162 patients with cardiovascular risk and LDL alterations.
Main Results:
- Random Forest Classifier (RFC) and Gradient Boosting Classifier (GBC) showed superior performance.
- These models effectively classified optimal LDL-lowering therapy.
- Naïve Bayes Classifier (NBC) was found unsuitable due to outcome overestimation.
Conclusions:
- Machine learning models, especially RFC, are valuable for optimizing LDL control in high-risk cardiovascular patients.
- AI enhances clinical decision-making by enabling personalized therapy selection.
- AI facilitates individualized treatment strategies based on specific patient risk factors.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Coronary Artery Disease IV: Preventive Measures
Improving Translational Accuracy
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...


